Determining the Competence of the Immune System over the First Year of Therapy in Patients with Malignant Glioma

What we are studying

To find out what happens with the immune system (the part of the body that helps fight infection and cancer) during the first year of treatment. In this study, we will measure the number of immune cells at several times during the first year of treatment. In the lab, we will measure whether these immune cells work correctly. We will also measure the response of the immune system to two vaccines to help find out how active patients' immune system are.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • Hispanic or Latino
  • Ages 18+

Eligibility Criteria

  • Brain tumor

What is involved

  • Blood draw
  • Baseline assessment
  • Vaccines


Parking will be validated for study related visits.

Contact Information

Study Coordinator
Jill Weber Pfefferkorn
Principal Investigator
Roy C. Strowd, MD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.